MicroTech Medical

**MicroTech Medical** is a pioneering company in the diabetes management medical devices industry, dedicated to reshaping the diabetes management paradigm globally. Established in **2011** and headquartered in **Hangzhou Future Sci-Tech City, China**, MicroTech Medical has been designated as the *Key Diabetes Research Center* in Zhejiang Province. The company boasts a strong in-house **R&D team of nearly 100**, with over *30%* holding a master or doctorate degree and significant experience in leading medical device companies. MicroTech Medical's product portfolio, including the *Equil Patch Insulin Pump*, *AiDEX Continuous Glucose Monitoring System (CGMS)*, *Blood Glucose Monitoring Systems (BGMS)*, and *POCT products*, exemplifies their commitment to innovation in diabetes management. Their last investment, totaling *CNY575.00M* in a **Series D investment on 28 December 2020**, attracted significant interest from notable venture capital firms such as **Lilly Asia Ventures**, **Qiming Venture Partners**, **Everbright**, **IDG Capital**, **3H Health Investment**, **Tengxun Touzi**, **CD Capital**, **Guofang Ziben**, **Taikang Touzi**, and **CICC Jiacheng Investment Management**. With a mission to provide greater freedom and flexibility to those living with diabetes, MicroTech Medical is poised for significant growth and impact in the global health care and manufacturing industries.

Connect with us on social media: Facebook: MicroTechMedicalDiabetes Instagram: microtech_medical Twitter: MicroTechDiabet Youtube: MicroTech Medical